<it>Nidogen 1 </it>and <it>2 </it>gene promoters are aberrantly methylated in human gastrointestinal cancer

<p>Abstract</p> <p>Background</p> <p>Nidogens are highly conserved proteins of basement membranes. Two nidogen proteins, nidogen 1 and nidogen 2, are known in mammals.</p> <p>Results</p> <p>We show that CpG islands of both NID1 and NID2 genes are...

Full description

Bibliographic Details
Main Authors: Sasaki Takako, Farinati Fabio, Manfredini Stefano, Angusti Angela, Gafà Roberta, Veronese Angelo, Miotto Elena, Sabbioni Silvia, Ulazzi Linda, Lanza Giovanni, Negrini Massimo
Format: Article
Language:English
Published: BMC 2007-02-01
Series:Molecular Cancer
Online Access:http://www.molecular-cancer.com/content/6/1/17
_version_ 1819032666502070272
author Sasaki Takako
Farinati Fabio
Manfredini Stefano
Angusti Angela
Gafà Roberta
Veronese Angelo
Miotto Elena
Sabbioni Silvia
Ulazzi Linda
Lanza Giovanni
Negrini Massimo
author_facet Sasaki Takako
Farinati Fabio
Manfredini Stefano
Angusti Angela
Gafà Roberta
Veronese Angelo
Miotto Elena
Sabbioni Silvia
Ulazzi Linda
Lanza Giovanni
Negrini Massimo
author_sort Sasaki Takako
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Nidogens are highly conserved proteins of basement membranes. Two nidogen proteins, nidogen 1 and nidogen 2, are known in mammals.</p> <p>Results</p> <p>We show that CpG islands of both NID1 and NID2 genes are aberrantly methylated in human cancer samples and cancer cell lines. For both genes, methylation was correlated with loss of gene transcription in human cell lines. Furthermore, demethylation of the NID1 and NID2 promoters restored gene transcription, demonstrating that methylation was responsible for silencing nidogen genes. In primary tumors, we detected NID1 promoter methylation in 67% of colon cancer samples and in 90% of gastric cancers. NID2 promoter was methylated in 29% of colon and 95% of gastric cancers. Immuno-staining for nidogen-2 confirmed the correlation between aberrant methylation and loss of nidogen expression also in primary tumors, implying that aberrant methylation was a mechanism for inhibiting nidogens expression in human gastrointestinal tumors.</p> <p>Conclusion</p> <p>These results suggest that loss of nidogens expression has a potential pathogenetic role in colon and stomach tumorigenesis. Nidogens are believed to connect laminin and collagen IV networks, hence stabilizing the basement membrane structure. Nidogens are also important for cell adhesion, as they establish contacts with various cellular integrins. Loss of nidogen expression may favor invasion and metastasis of cancer cells by loosening cell interaction with basal membrane and by weakening the strength of the basement membrane itself, first barrier from the connective vascularized matrix.</p>
first_indexed 2024-12-21T07:05:34Z
format Article
id doaj.art-848f4f6c05774c1898edb95cc0082f0f
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-12-21T07:05:34Z
publishDate 2007-02-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-848f4f6c05774c1898edb95cc0082f0f2022-12-21T19:12:06ZengBMCMolecular Cancer1476-45982007-02-01611710.1186/1476-4598-6-17<it>Nidogen 1 </it>and <it>2 </it>gene promoters are aberrantly methylated in human gastrointestinal cancerSasaki TakakoFarinati FabioManfredini StefanoAngusti AngelaGafà RobertaVeronese AngeloMiotto ElenaSabbioni SilviaUlazzi LindaLanza GiovanniNegrini Massimo<p>Abstract</p> <p>Background</p> <p>Nidogens are highly conserved proteins of basement membranes. Two nidogen proteins, nidogen 1 and nidogen 2, are known in mammals.</p> <p>Results</p> <p>We show that CpG islands of both NID1 and NID2 genes are aberrantly methylated in human cancer samples and cancer cell lines. For both genes, methylation was correlated with loss of gene transcription in human cell lines. Furthermore, demethylation of the NID1 and NID2 promoters restored gene transcription, demonstrating that methylation was responsible for silencing nidogen genes. In primary tumors, we detected NID1 promoter methylation in 67% of colon cancer samples and in 90% of gastric cancers. NID2 promoter was methylated in 29% of colon and 95% of gastric cancers. Immuno-staining for nidogen-2 confirmed the correlation between aberrant methylation and loss of nidogen expression also in primary tumors, implying that aberrant methylation was a mechanism for inhibiting nidogens expression in human gastrointestinal tumors.</p> <p>Conclusion</p> <p>These results suggest that loss of nidogens expression has a potential pathogenetic role in colon and stomach tumorigenesis. Nidogens are believed to connect laminin and collagen IV networks, hence stabilizing the basement membrane structure. Nidogens are also important for cell adhesion, as they establish contacts with various cellular integrins. Loss of nidogen expression may favor invasion and metastasis of cancer cells by loosening cell interaction with basal membrane and by weakening the strength of the basement membrane itself, first barrier from the connective vascularized matrix.</p>http://www.molecular-cancer.com/content/6/1/17
spellingShingle Sasaki Takako
Farinati Fabio
Manfredini Stefano
Angusti Angela
Gafà Roberta
Veronese Angelo
Miotto Elena
Sabbioni Silvia
Ulazzi Linda
Lanza Giovanni
Negrini Massimo
<it>Nidogen 1 </it>and <it>2 </it>gene promoters are aberrantly methylated in human gastrointestinal cancer
Molecular Cancer
title <it>Nidogen 1 </it>and <it>2 </it>gene promoters are aberrantly methylated in human gastrointestinal cancer
title_full <it>Nidogen 1 </it>and <it>2 </it>gene promoters are aberrantly methylated in human gastrointestinal cancer
title_fullStr <it>Nidogen 1 </it>and <it>2 </it>gene promoters are aberrantly methylated in human gastrointestinal cancer
title_full_unstemmed <it>Nidogen 1 </it>and <it>2 </it>gene promoters are aberrantly methylated in human gastrointestinal cancer
title_short <it>Nidogen 1 </it>and <it>2 </it>gene promoters are aberrantly methylated in human gastrointestinal cancer
title_sort it nidogen 1 it and it 2 it gene promoters are aberrantly methylated in human gastrointestinal cancer
url http://www.molecular-cancer.com/content/6/1/17
work_keys_str_mv AT sasakitakako itnidogen1itandit2itgenepromotersareaberrantlymethylatedinhumangastrointestinalcancer
AT farinatifabio itnidogen1itandit2itgenepromotersareaberrantlymethylatedinhumangastrointestinalcancer
AT manfredinistefano itnidogen1itandit2itgenepromotersareaberrantlymethylatedinhumangastrointestinalcancer
AT angustiangela itnidogen1itandit2itgenepromotersareaberrantlymethylatedinhumangastrointestinalcancer
AT gafaroberta itnidogen1itandit2itgenepromotersareaberrantlymethylatedinhumangastrointestinalcancer
AT veroneseangelo itnidogen1itandit2itgenepromotersareaberrantlymethylatedinhumangastrointestinalcancer
AT miottoelena itnidogen1itandit2itgenepromotersareaberrantlymethylatedinhumangastrointestinalcancer
AT sabbionisilvia itnidogen1itandit2itgenepromotersareaberrantlymethylatedinhumangastrointestinalcancer
AT ulazzilinda itnidogen1itandit2itgenepromotersareaberrantlymethylatedinhumangastrointestinalcancer
AT lanzagiovanni itnidogen1itandit2itgenepromotersareaberrantlymethylatedinhumangastrointestinalcancer
AT negrinimassimo itnidogen1itandit2itgenepromotersareaberrantlymethylatedinhumangastrointestinalcancer